Detalhe da pesquisa
1.
Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients.
Breast Cancer Res Treat
; 176(2): 253-260, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30900138
2.
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature.
Breast Cancer Res Treat
; 153(3): 617-24, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26358708
3.
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.
Cancer
; 120(17): 2657-64, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24930388
4.
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.
Breast Cancer Res Treat
; 146(1): 7-14, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24899084
5.
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease.
J Clin Oncol
; 41(8): 1501-1510, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881998
6.
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer.
J Clin Oncol
; 41(9): 1638-1645, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921335
7.
Dual HER2-targeted approaches in HER2-positive breast cancer.
Breast Cancer Res Treat
; 131(2): 371-83, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21956210
8.
Multiple receptor conversions during the course of metastatic breast cancer therapy: a case report and review of the literature.
J Med Case Rep
; 16(1): 461, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510266
9.
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.
Cancer Manag Res
; 11: 513-524, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655702
10.
Testing a positive-affect induction to reduce verbally induced nocebo hyperalgesia in an experimental pain paradigm.
Pain
; 160(10): 2290-2297, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31107412
11.
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.
Clin Breast Cancer
; 7(9): 690-6, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17919349
12.
Highlights in metastatic breast cancer from the 2011 San Antonio Breast Cancer Symposium (SABCS).
Clin Adv Hematol Oncol
; 10(2 Suppl 2): 1-24, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22398689
13.
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.
J Clin Oncol
; 23(6): 1178-84, 2005 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15718314
14.
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.
J Clin Oncol
; 22(19): 3893-901, 2004 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15459210
15.
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.
J Clin Oncol
; 20(3): 719-26, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11821453
16.
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
J Clin Oncol
; 21(15): 2889-95, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12885806
17.
Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
Clin Breast Cancer
; 6(2): 132-42, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16001991
18.
Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab.
Clin Breast Cancer
; 6(3): 240-6, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16137435
19.
Defining the survival benchmark for breast cancer patients with systemic relapse.
Breast Cancer (Auckl)
; 9: 9-17, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25922577
20.
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.
Semin Oncol
; 31(6 Suppl 13): 106-46, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15717740